SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zim Laboratories to invest Rs 30 lakh in subsidiary

26 Aug 2019 Evaluate

Zim Laboratories has received an approval for investment of Rs 30,00,000 in the equity shares of ZIM Health Technologies, a wholly-owned Subsidiary of the company. The Board of Directors of the company at its meeting held on August 24, 2019, approved the same.

Zim Laboratories has established itself as one of the preferred healthcare solution providers in the field of New Drug Delivery Systems (NDDS).

Zim Laboratories Share Price

80.00 0.28 (0.35%)
20-Apr-2026 14:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.40
Dr. Reddys Lab 1234.00
Cipla 1233.00
Zydus Lifesciences 939.55
Lupin 2330.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×